Walter, R. B., Othus, M., Löwenberg, B., Ossenkoppele, G. J., Petersdorf, S. H., Pabst, T., … Estey, E. H. (2015). Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica, 100(10), e409–e411. https://doi.org/10.3324/haematol.2015.130013

Walter, Roland B., Megan Othus, Bob Löwenberg, Gert J. Ossenkoppele, Stephen H. Petersdorf, Thomas Pabst, Marie-Christiane Vekemans, Frederick R. Appelbaum, Harry P. Erba, and Elihu H. Estey. “Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.” Haematologica 100, no. 10 (October 2015): e409–11. https://doi.org/10.3324/haematol.2015.130013.

Walter RB, Othus M, Löwenberg B, Ossenkoppele GJ, Petersdorf SH, Pabst T, et al. Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica. 2015 Oct;100(10):e409–11.

Walter, Roland B., et al. “Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.” Haematologica, vol. 100, no. 10, Oct. 2015, pp. e409–11. Pubmed, doi:10.3324/haematol.2015.130013.

Walter RB, Othus M, Löwenberg B, Ossenkoppele GJ, Petersdorf SH, Pabst T, Vekemans M-C, Appelbaum FR, Erba HP, Estey EH. Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica. 2015 Oct;100(10):e409–e411.